Authors: Nuijten, MJC Engelfriet, P Duijn, K Bruijn, G Wierz, D Koopmanschap, M

Citation: Mjc. Nuijten et al., A cost-cost study comparing etanercept with infliximab in rheumatoid arthritis, PHARMACOECO, 19(10), 2001, pp. 1051-1064

Authors: McDonnell, J Busschbach, JJV Kok, E van Exel, J Stolk, E Koopmanschap, M Rutten, FFH

Citation: J. Mcdonnell et al., Lower urinary tract symptoms suggestive of benign prostatic obstruction - Triumph: Health-economical analysis, EUR UROL, 39, 2001, pp. 37-41

Authors: Rutten, F Bleichrodt, H Brouwer, W Koopmanschap, M Schut, E

Citation: F. Rutten et al., Handbook of health economics, vol 1a-1b, J HEALTH EC, 20(5), 2001, pp. 855-879

Authors: Curran, D Aaronson, N Standaert, B Molenberghs, G Therasse, P Ramirez, A Koopmanschap, M Erder, H Piccart, M

Citation: D. Curran et al., Summary measures and statistics in the analysis of quality of life data: an example from an EORTC-NCIC-SAKK locally advanced breast cancer study, EUR J CANC, 36(7), 2000, pp. 834-844